StudyFinds' Dr. Faith Coleman looks at the common mistakes patients make using GLP-1 agonists like Ozempic and Wegovy.

The trial didn't include an arm comparing the combination to Trulicity alone, but if it had, it looks likely that the two drugs together wouldn't have outperformed the GLP-1 as a monotherapy.

The Government is considering using drugs to help get obese people back to work - but they can lead to serious health ...

This story is part of "Out of Stock: Investigating America's Drug Shortage Crisis," a series exploring the causes and ...

A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...

Diabetes medications like Ozempic and Trulicity are typically covered, while weight loss drugs like Wegovy and Saxenda face limited coverage unless specific health criteria are met. Ren-Fielding ...

“Stelara, an auto-immune biologic, has become a key earner for Johnson & Johnson, and the diabetes drug Trulicity is expected to enjoy strong sales momentum over the forecast period 2018-2025." ...

Medicare Advantage plans are government Medicare benefits provided through for-profit insurers, so plan terms can — and do — change ...

We recently compiled a list of the 10 Most Promising Growth Stocks According to Hedge Funds. In this article, we are going to ...

Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro ...

Here, the authors present CYpHER, a TPD tool that uses molecules engineered for intracellular target release with drug recycling via transferrin receptor. CYpHER induces depletion of extracellular ...

It also explores the risks of untreated disease and whether can you die if you stop taking levothyroxine or other thyroid drugs. Medications are a major part of the treatment of hypothyroidism and ...